• Join Our Team
Curant Health
  • Home
  • About
  • For Patients
  • Providers
  • Health Plans
  • Pharma
  • Employers
  • Contact Us
Select Page

How to smooth the patient access path to life-altering therapies

by Administrator | Oct 16, 2015 | blog

The newly approved PCSK9 inhibitors are a major advance in cholesterol-lowering drug therapy.  Gregory Curfman, MD and Editor in Chief of Harvard Health Publications, has said that this advanced therapy may just rewrite the script for treating patients with chronic...

Recent Posts

  • Committed to Continuity of Patient Care: COVID-19 Update
  • Outcomes Speak Louder Than Words®
  • Improve Medication Adherence in Patients with HIV
  • Patient Management For HIV: The Lifesaving Story Of Robert W.
  • Flipping the Script: The Complexities of the Health Care System and the Importance of Cancer Care Management

Recent Comments

    • Terms & Conditions
    • Web Policies
    • Privacy Practices
    • Careers
    ×

    ×

    Get in Touch

    Contact Info

    et|icon_phone|
    (404) 217-4896
    et|icon_mail_alt|

    CurantMeansCare@curanthealth.com